v3.26.1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Company’s Segments Including a Reconciliation to Income Before Taxes

The tables below provide information about the Company’s segments and include a reconciliation to income before taxes:

Three Months Ended March 31, 2026  Fertility Clinic Services   INVOcell Device   Total 
Revenue from external customers  $1,983,540   $32,992   $2,016,532 
Intersegment revenues   -    12,000    12,000 
 Total revenue    1,983,540    44,992    2,028,532 
Reconciliation of revenue               
Elimination of intersegment revenue             (12,000)
Total consolidated revenue             2,016,532 
Less:               
Cost of revenue   1,282,247    5,152    1,287,399 
Sales and marketing   21,112    -    21,112 
General and administrative   514,929    -    514,929 
Depreciation and amortization   34,821    2,431    37,252 
Segment profit  $130,431   $37,409    155,840 
Reconciliation of net loss               
Other income (loss)             22,168 
Interest expense             (180,323)
Unallocated amounts:               
Other corporate expenses             (1,745,504)
Loss before taxes            $(1,747,819)
                
Assets  $ 6,238,540   $29,809      

 

 

Three Months Ended March 31, 2025  Fertility Clinic Services   INVOcell Device   Therapeutics   Total 
Revenue from external customers  $1,621,553   $15,632   $-   $1,637,185 
Intersegment revenues   -    4,500    -    4,500 
 Total revenue    1,621,553    20,132    -    1,641,685 
Reconciliation of revenue                    
Elimination of intersegment revenue                  (4,500)
Total consolidated revenue                  1,637,185 
Less:                    
Cost of revenue   1,060,243    3,984    -    1,064,227 
Sales and marketing   12,974    -    -    12,974 
General and administrative   307,101    -    1,000,583    1,307,684 
Research and development   -    -    265,663    265,663 
Impairment loss   -    -    14,645,069    14,645,069 
Depreciation and amortization   212,456    2,431    -    214,887 
Segment profit (loss)  $28,778   $13,717   $(15,911,315)   (15,873,319)
Reconciliation of net loss                    
Other income (loss)                  15,096 
Interest expense                  (307,839)
Unallocated amounts:                    
Other corporate expenses                  (1,237,524)
Loss before taxes                 $(17,403,586)
                     
Assets  $10,654,643   $39,534   $16,942,932